SFG
KLRS

SVB Financial Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

SVB Financial Group’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-748
Closed -$37K – 21
2023
Q3 		$37K Sell
748
-374
-33% -$18.5K 0.07% 17
2023
Q2 		$87.8K Sell
1,122
-374
-25% -$29.3K 0.17% 19
2023
Q1 		$136K Sell
1,496
-374
-20% -$33.9K 0.26% 18
2022
Q4 		$221K Buy
+1,870
New +$221K 0.6% 15